According to the current analysis of Reports and Data, the global Hemophilia Genetics Market was valued at USD 12.41 Billion in 2020 and is expected to reach USD 18.75 Billion by the year 2028, at a CAGR of 5.20%. Hemophilia Genetics is a rare genetic disorder in which blood doesn't clot normally because it lacks sufficient blood-clotting proteins known as clotting factors. Among the...